Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy
- 3 October 2006
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (40) , 14889-14894
- https://doi.org/10.1073/pnas.0604045103
Abstract
Alterations in phosphorylation of cellular proteins are a hallmark of malignant transformation. Degradation of these phosphoproteins could generate cancer-specific class I MHC-associated phosphopeptides recognizable by CD8+ T lymphocytes. In a comparative analysis of phosphopeptides presented on the surface of melanoma, ovarian carcinoma, and B lymphoblastoid cells, we find 5 of 36 that are restricted to the solid tumors and common to both cancers. Differential presentation of these peptides can result from differential phosphorylation of the source proteins. Recognition of the peptides on cancer cells by phosphopeptide-specific CD8+ T lymphocytes validates the potential of these phosphopeptides as immunotherapeutic targets.Keywords
This publication has 36 references indexed in Scilit:
- Overexpression of Insulin Receptor Substrate-2 in Human and Murine Hepatocellular CarcinomaThe American Journal of Pathology, 2005
- SCF-mediated protein degradation and cell cycle controlOncogene, 2005
- Involvement of Insulin Receptor Substrate 2 in Mammary Tumor MetastasisMolecular and Cellular Biology, 2004
- The significance of the Wnt pathway in the pathology of human cancersPathology, 2004
- MAPKAP Kinase 2 Phosphorylates Tristetraprolin on in Vivo Sites Including Ser178, a Site Required for 14-3-3 BindingJournal of Biological Chemistry, 2004
- Ratchets and clocks: the cell cycle, ubiquitylation and protein turnoverNature Reviews Molecular Cell Biology, 2003
- Tumor Antigens and Proteomics from the Point of View of the Major Histocompatibility Complex PeptidesMolecular & Cellular Proteomics, 2003
- Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiaeNature Biotechnology, 2002
- DEGRADATION OF CELL PROTEINS AND THE GENERATION OF MHC CLASS I-PRESENTED PEPTIDESAnnual Review of Immunology, 1999
- Partial purification and some properties of BB7.2 a cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28Human Immunology, 1981